Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis

被引：0
|
作者：
G. Wheater
V. E. Hogan
Y. K. O. Teng
J. Tekstra
F. P. Lafeber
T. W. J. Huizinga
J. W. J. Bijlsma
R. M. Francis
S. P. Tuck
H. K. Datta
J. M. van Laar
机构：
[1] The James Cook University Hospital,Department of Biochemistry
[2] Newcastle University,Musculoskeletal Research Group, Institute of Cellular Medicine
[3] Leiden University Medical Centre,Department of Rheumatology
[4] University Medical Centre Utrecht,Department of Rheumatology and Clinical Immunology
[5] Newcastle University,Institute for Ageing and Health
[6] The James Cook University Hospital,Department of Rheumatology
来源：
Osteoporosis International | 2011年 / 22卷
关键词：
B cell; Bone turnover; Inflammation; Osteoclastogenesis; Osteoporosis; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：3067 / 3072
页数：5
相关论文
共 50 条
  • [31] EVIDENCE FOR B-CELL ACTIVATION IN PATIENTS WITH ACTIVE RHEUMATOID-ARTHRITIS
    YOUINOU, PY
    IRVING, WL
    SHIPLEY, M
    HAYES, J
    LYDYARD, PM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1984, 55 (01): : 91 - 98
  • [32] B-CELL SUBPOPULATIONS DIFFER IN RHEUMATOID ARTHRITIS PATIENTS WITH AND WITHOUT AUTOANTIBODIES
    Thorarinsdottir, K.
    Jirholt, P.
    Jacobsson, L.
    Martensson, I. -L.
    Gjertsson, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 355 - 355
  • [33] EFFECT OF SULFASALAZINE ON B-CELL HYPERACTIVITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    IMAI, F
    SUZUKI, T
    ISHIBASHI, T
    TANAKA, M
    AKIYAMA, Y
    DOHI, Y
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (04) : 612 - 615
  • [34] SERUM RITUXIMAB LEVELS AND EFFICIENCY OF B-CELL DEPLETION: DIFFERENCES BETWEEN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
    Reddy, V.
    Croca, S.
    Gerona, D.
    Ortega, I. D. L. T.
    Isenberg, D.
    Leandro, M.
    Cambridge, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 532 - 532
  • [35] SERUM RITUXIMAB LEVELS AND EFFICIENCY OF B-CELL DEPLETION: DIFFERENCES BETWEEN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
    Reddy, Venkat
    Croca, Sara
    Gerona, Delia
    De La Torre Ortega, Inmaculada
    Isenberg, David A.
    Leandro, Maria
    Cambridge, Geraldine
    RHEUMATOLOGY, 2013, 52 : 132 - 132
  • [36] Serum Rituximab Levels and Efficiency of B-Cell Depletion: Differences Between Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
    Reddy, Venkat
    Croca, Sara
    Gerona, Delia
    Ortega, Inmaculada De La Torre
    Isenberg, David A.
    Leandro, Maria
    Cam-bridge, Geraldine
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S282 - S282
  • [37] Does infliximab decrease bone turnover in rheumatoid arthritis patients
    Korczowska, I
    Hrycaj, P
    Lacki, JK
    JOINT BONE SPINE, 2003, 70 (05) : 398 - 400
  • [38] Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody (HORUS TRIAL)
    Mohsen Elshahaly
    Gillian Wheater
    Kamran Naraghi
    Stephen P Tuck
    Harish K Datta
    Wan-Fai Ng
    Jacob M van Laar
    BMC Musculoskeletal Disorders, 14 (Suppl 1)
  • [39] STUDY OF CORRELATION OF B-CELL LEVEL AND PROGRESSION OF BONE DESTRUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING RITUXIMAB THERAPY
    Kudryavtseva, A.
    Lukina, G.
    Smirnov, A.
    Glukhova, S.
    Aronova, E.
    Gridneva, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1447 - 1447
  • [40] Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis
    Adami, Giovanni
    Orsolini, Giovanni
    Rossini, Maurizio
    Fratucello, Anna
    Fassio, Angelo
    Viapiana, Ombretta
    Fracassi, Elena
    Bixio, Riccardo
    Gatti, Davide
    BMC RHEUMATOLOGY, 2024, 8 (01)
12345